Phase 3 Trial of Vertex's Islet Cell Therapy for Type 1 Diabetes in Under Way

Retrieved on: 2025-04-23 19:36:18

Tags for this article:

Click the tags to see associated articles and topics

Phase 3 Trial of Vertex's Islet Cell Therapy for Type 1 Diabetes in Under Way. View article details on hiswai:

Excerpt

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes.

Article found on: www.managedhealthcareexecutive.com